{"id":"https://openalex.org/W4396582616","doi":"https://doi.org/10.3389/fonc.2024.1380584","title":"KRAS G12C inhibitor combination therapies: current evidence and challenge","display_name":"KRAS G12C inhibitor combination therapies: current evidence and challenge","alternate_titles":[],"publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396582616","doi":"https://doi.org/10.3389/fonc.2024.1380584","pmid":"https://pubmed.ncbi.nlm.nih.gov/38756650","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11097198"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2024.1380584","doi":"https://doi.org/10.3389/fonc.2024.1380584","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1380584","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1380584/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4396582616"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1380584/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057695365","display_name":"Hirotaka Miyashita","orcid":"https://orcid.org/0000-0002-0433-9779","observed_orcids":["https://orcid.org/0000-0002-0433-9779"]},"institutions":[{"id":"https://openalex.org/I1289422878","display_name":"Dartmouth\u2013Hitchcock Medical Center","ror":"https://ror.org/00d1dhh09","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I107672454","https://openalex.org/I1289422878","https://openalex.org/I4390039337"]},{"id":"https://openalex.org/I4390039367","display_name":"Dartmouth Cancer Center","ror":"https://ror.org/044b05b34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039367"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Hirotaka Miyashita","raw_affiliation_strings":["Hematology and Oncology, Dartmouth Cancer Center, Lebanon, NH, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology, Dartmouth Cancer Center, Lebanon, NH, United States","institution_ids":["https://openalex.org/I1289422878","https://openalex.org/I4390039367"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086626483","display_name":"Shumei Kato","orcid":"https://orcid.org/0000-0003-1193-1815","observed_orcids":["https://orcid.org/0000-0003-1193-1815"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Shumei Kato","raw_affiliation_strings":["Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, United States","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"David S. Hong","raw_affiliation_strings":["Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5026095888"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":3.4581,"has_fulltext":true,"cited_by_count":106,"citation_normalized_percentile":{"value":0.95649733,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"14","issue":null,"first_page":"1380584","last_page":"1380584"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.06159999966621399,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.04019999876618385,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c-inhibitors","display_name":"KRAS G12C inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9700000286102295},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7089999914169312},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9010000228881836},{"id":"https://openalex.org/keywords/sos1-inhibitor","display_name":"SOS1 inhibitor","score":0.8050000071525574},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/shp2-inhibitors","display_name":"SHP2 inhibitors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/erk-inhibitor","display_name":"ERK inhibitor","score":0.6970000267028809},{"id":"https://openalex.org/keywords/fak-inhibitors","display_name":"FAK inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/kras-targeted-therapy","display_name":"KRAS-targeted therapy","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9891727566719055},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7013266682624817},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.6249940395355225},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5568236708641052},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5365872979164124},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4682271182537079},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.44960999488830566},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4272809624671936},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.41917771100997925},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35558104515075684},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.255512535572052},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.24787721037864685},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.2082190215587616},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14632189273834229},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fonc.2024.1380584","doi":"https://doi.org/10.3389/fonc.2024.1380584","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1380584","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1380584/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11097198","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11097198","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11097198/pdf/fonc-14-1380584.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:38756650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38756650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:digitalcommons.library.tmc.edu:uthgsbs_docs-2034","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.library.tmc.edu/uthgsbs_docs/1063","pdf_url":null,"source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Faculty, Staff and Student Publications","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:4077e8913381419588d33f240e743af9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4077e8913381419588d33f240e743af9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 14 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2024.1380584","doi":"https://doi.org/10.3389/fonc.2024.1380584","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1380584","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1380584/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396582616.pdf","grobid_xml":"https://content.openalex.org/works/W4396582616.grobid-xml"},"referenced_works_count":97,"referenced_works":["https://openalex.org/W1902804987","https://openalex.org/W1941703300","https://openalex.org/W1967323308","https://openalex.org/W2002252224","https://openalex.org/W2044423100","https://openalex.org/W2071018921","https://openalex.org/W2083695927","https://openalex.org/W2096238248","https://openalex.org/W2100439220","https://openalex.org/W2112845420","https://openalex.org/W2122184612","https://openalex.org/W2128339707","https://openalex.org/W2146375441","https://openalex.org/W2157769714","https://openalex.org/W2166084034","https://openalex.org/W2180481128","https://openalex.org/W2262414037","https://openalex.org/W2318605753","https://openalex.org/W2528438395","https://openalex.org/W2620099337","https://openalex.org/W2748710555","https://openalex.org/W2765125878","https://openalex.org/W2782863308","https://openalex.org/W2785589654","https://openalex.org/W2885938058","https://openalex.org/W2888731232","https://openalex.org/W2892347132","https://openalex.org/W2895923466","https://openalex.org/W2947368578","https://openalex.org/W2962640793","https://openalex.org/W2973796265","https://openalex.org/W2977895282","https://openalex.org/W2982321167","https://openalex.org/W2982602983","https://openalex.org/W2990053855","https://openalex.org/W2996719044","https://openalex.org/W2999810289","https://openalex.org/W3028041439","https://openalex.org/W3039981956","https://openalex.org/W3077914340","https://openalex.org/W3080542372","https://openalex.org/W3100506521","https://openalex.org/W3130115867","https://openalex.org/W3137170664","https://openalex.org/W3137382409","https://openalex.org/W3157480760","https://openalex.org/W3172081492","https://openalex.org/W3174662367","https://openalex.org/W3175323447","https://openalex.org/W3186741379","https://openalex.org/W4200037575","https://openalex.org/W4200096031","https://openalex.org/W4200195771","https://openalex.org/W4200595129","https://openalex.org/W4223470164","https://openalex.org/W4225576930","https://openalex.org/W4281650778","https://openalex.org/W4282981218","https://openalex.org/W4283259595","https://openalex.org/W4292566549","https://openalex.org/W4296771041","https://openalex.org/W4296809296","https://openalex.org/W4297075058","https://openalex.org/W4307975982","https://openalex.org/W4309412451","https://openalex.org/W4310780368","https://openalex.org/W4312094134","https://openalex.org/W4312094576","https://openalex.org/W4362541388","https://openalex.org/W4362543843","https://openalex.org/W4365514056","https://openalex.org/W4366198986","https://openalex.org/W4367041654","https://openalex.org/W4378745178","https://openalex.org/W4378901135","https://openalex.org/W4379281494","https://openalex.org/W4379282285","https://openalex.org/W4379283799","https://openalex.org/W4379468630","https://openalex.org/W4386116142","https://openalex.org/W4387609462","https://openalex.org/W4387642987","https://openalex.org/W4387809560","https://openalex.org/W4387811516","https://openalex.org/W4387811556","https://openalex.org/W4387811989","https://openalex.org/W4387859726","https://openalex.org/W4388044309","https://openalex.org/W4388046002","https://openalex.org/W4388484248","https://openalex.org/W4388858129","https://openalex.org/W4389227351","https://openalex.org/W4389227556","https://openalex.org/W4389242297","https://openalex.org/W4389338940","https://openalex.org/W4389670848","https://openalex.org/W4390582065"],"related_works":["https://openalex.org/W3108346189","https://openalex.org/W4400906074","https://openalex.org/W4313706696","https://openalex.org/W4284680070","https://openalex.org/W4284670262","https://openalex.org/W4378219678","https://openalex.org/W4408932009","https://openalex.org/W4320490403","https://openalex.org/W4392847794","https://openalex.org/W4396873083"],"abstract_inverted_index":{"Although":[0],"KRAS":[1,7,14,33,65,71,81,105,119,143,158],"G12C":[2,15,34,66,82,106,120,144],"inhibitors":[3,35,69,83,121,159],"have":[4,18,47,58,101,126],"proven":[5],"that":[6],"is":[8,163],"a":[9,167],"\"druggable\"":[10],"target":[11],"of":[12,32,78,80,118,153],"cancer,":[13],"inhibitor":[16],"monotherapies":[17],"demonstrated":[19,59],"limited":[20,141],"clinical":[21,51,76],"efficacy":[22,61],"due":[23],"to":[24,53,142,165],"primary":[25],"and":[26,44,67,93,113,124,130],"acquired":[27],"resistance":[28],"mechanisms.":[29],"Multiple":[30],"combinations":[31,79,107,117],"with":[36,84,108,122,160],"other":[37,85,161],"targeted":[38,86],"therapies,":[39,87],"such":[40,88],"as":[41,89],"RTK,":[42],"SHP2,":[43],"MEK":[45],"inhibitors,":[46,110,112],"been":[48,128],"investigated":[49],"in":[50,170],"trials":[52,77],"overcome":[54],"the":[55,131,150],"resistance.":[56],"They":[57],"promising":[60,104],"especially":[62],"by":[63],"combining":[64,157],"EGFR":[68],"for":[70,173],"G12C-mutated":[72],"colorectal":[73],"cancer.":[74],"Many":[75],"SOS1,":[90],"ERK,":[91],"CDK4/6,":[92],"wild-type":[94],"RAS,":[95],"are":[96,145],"ongoing.":[97],"Furthermore,":[98],"preclinical":[99],"data":[100],"suggested":[102],"additional":[103],"YAP/TAZ-TEAD":[109],"FAK":[111],"farnesyltransferase":[114],"inhibitors.":[115],"The":[116],"immunotherapies":[123],"chemotherapies":[125],"also":[127],"investigated,":[129],"preliminary":[132],"results":[133],"were":[134],"reported.":[135],"More":[136],"recently,":[137],"KRAS-targeted":[138],"therapies":[139],"not":[140],"being":[146],"developed,":[147],"potentially":[148],"broadening":[149],"treatment":[151,172],"landscape":[152],"KRAS-mutated":[154,174],"cancers.":[155],"Rationally":[156],"therapeutics":[162],"likely":[164],"play":[166],"significant":[168],"role":[169],"future":[171],"solid":[175],"tumors.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4396582616","counts_by_year":[{"year":2026,"cited_by_count":54},{"year":2025,"cited_by_count":35},{"year":2024,"cited_by_count":17}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2024-05-03T00:00:00"}
